Daridorexant

(Quviviq)

Daridorexant

Drug updated on 11/15/2023

Dosage FormTablets (oral; 25 mg, 50 mg)
Drug ClassOrexin receptor antagonists
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • For the treatment of adult patients with insomnia characterized by difficulties with sleep onset and/or sleep maintenance.